Embed this press release by copying the code below:
Investor Investigation over Potential Wrongdoing at Asterias Biotherapeutics Inc (NYSEMKT:AST)
Investor Investigation over Potential Wrongdoing at Asterias Biotherapeutics Inc (NYSEMKT:AST)